News

News

Synthace appoints Dr. Donald Deieso as new board chair

Dr. Deieso joins at a time of strong momentum: Series C raised in the last year, a doubling of ARR, and expansion to 8 of the world’s top pharma companies.

Will Patrick

 4 min

Featured

Synthace Named a 2022 UK’s Best Workplaces™ for Women

We are delighted to announce that Great Place to Work UK have recognized Synthace in their annual listing of UK companies.

Will Patrick

 6 min

News

UCL Selects Synthace to Help Make Digital, Cloud-Based Lab Work a Reality

Building a lab of the future? You're not alone. UCL selects Synthace to help them bridge the gap between digital and physical spaces.

Will Patrick

 4 min

News

IDBS Partnership to Streamline Bioprocess Data Management

Synthace is proud to announce our strategic partnership with IDBS to provide users with state-of-the-art data foundations for experimentation.

Synthace Team

 4 min

News

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Synthace is proud to announce that we have raised $35M to expand Access to our revolutionary R&D Technology. Learn more on our website today.

Synthace Team

 9 min

News

Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists

First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.

Synthace Team

 8 min

People

Synthace CEO on Scaling Innovative Companies and Accelerating Life Sciences

Synthace's CEO Guy Levy-Yurista talks about his journey into biotech, his plans for Synthace & the steps he's taking to strengthen the company culture.

Synthace Team

 14 min

News

Veteran Technology Executive Joins Synthace to Accelerate Its Mission to Revolutionize the Life Science Research Market

Synthace hires Guy Levy-Yurista as Chief Executive Officer.

Synthace Team

 4 min

News

Synthace More than Doubles Its Annual Recurring Revenue; Expands Customer Footprint with the Top Pharma Companies in 2020

Strong financial performance and achievement of other key milestones demonstrate the growing strength of Synthace’s offering within biopharma and biotech.

Synthace Team

 5 min